Freedom Capital analyst Keith Hinton initiated coverage of Alphatec (ATEC) with a Buy rating and $25 price target The firm thinks the pure-play spine medtech company can continue to grow well above the market as the company leverages its differentiated strategy, lateral portfolio and growing scale to take share, the analyst tells investors.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ATEC: